MOORESTOWN, New Jersey—Tabula Rasa HealthCare, Inc. (TRHC), a health care technology company advancing the safe use of medications, announced the appointment of Brian Adams as president and chief executive officer. Adams, who was serving as TRHC's interim chief executive officer since September 2022 and previously served as the company's co-president and chief financial officer, was also appointed to the TRHC's Board of Directors as a Class I director, effective immediately.
"I greatly appreciate the Board's trust and belief in me, and I am honored to continue working alongside a talented management team and dedicated employee base," Adams said. "Over the past few months, we have made significant strides refocusing our business around our solutions for PACE, our fastest-growing market, and we are committed to advancing these offerings in order to support future growth and enhance our client experience. Our combination of solutions is not only relevant in PACE, but also to adjacent health care markets taking on financial risk and serving similar demographics and I am excited to capitalize on these opportunities. The Board and the leadership team are confident in our current market position and look forward to keeping the momentum going as we continue to make positive impacts on patient care for our clients."
TRHC also announced Richard W. Rew II has joined the as chief legal officer and corporate secretary, effective April 10, 2023. Rew joins from IsoPlexis Corporation, where he served as senior vice president, general counsel and secretary. As chief legal officer, Rew will be responsible for legal operations, litigation, corporate governance and regulatory affairs. Rew will report to Adams.
In addition, TRHC reported preliminary unaudited estimated revenue from continuing operations for the quarter that ended March 31, 2023.
